Navigation Links
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Date:8/19/2007

membership agreements, customized IT systems, and an integrated tissue bank. For more information, please visit http://www.themmrc.org.

About Proteolix

Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers and immunological conditions by inhibiting the proteasome and thereby disrupting protein turnover in cells. In addition to its lead product candidate, carfilzomib (PR-171), which is delivered intravenously and is currently in multiple clinical trials to evaluate its safety and efficacy in different types of cancer, Proteolix is developing next generation proteasome inhibitors, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor, to expand the therapeutic potential of this new target class. Proteolix is headquartered in South San Francisco. For more information, please visit the Company's website at http://www.proteolix.com.

MMRC Contact: Anne Quinn Young, Program Director, 203-652-0212

Proteolix Contact: Stephen R. Brady, Executive Director of Business & Legal Affairs, 650-615-7521


'/>"/>
SOURCE Proteolix

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Future ... report titled, "Continuous Glucose Monitoring Systems Market: Global Industry ... the report, the global continuous glucose monitoring systems market ... is expected to reach US$ 788.4 Mn by 2020, ... 2015 to 2020. Global continuous glucose monitoring ...
(Date:7/30/2015)... --  Gaumard® Scientific Company today announced that ... operating system to support an entire family of ... users. UNI® version 2.27.21.0 adds enhanced functionality including ... well as improvements to laboratory functions, patient charting ... EtCO 2 .  First launched ...
(Date:7/30/2015)...  Big Cloud Analytics, Inc. (BCA), a leading ... is working with Intel Corporation to showcase Internet ... Martin Healthcare Technology Alliance. The recently formed alliance ... medical technology companies and academic institutions. Its purpose ... care in rapidly evolving and growing areas of ...
Breaking Medicine Technology:Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3
... Allied Healthcare Products, Inc. (NASDAQ: AHPI ) reported a ... Allied,s net loss for the first quarter of its 2012 ... basic and diluted share, versus a loss of about $88,000, or ... quarter. Allied,s sales for the quarter ending September 30, ...
... FDA approved Makena (hydroxyprogesterone caproate) in February 2011 for ... in women who have had at least one prior ... a version of the active ingredient of Makena has ... from a pharmacist who compounded the drug.  In March ...
Cached Medicine Technology:Allied Healthcare Products Reports First Quarter Loss on Sales Decline 2Allied Healthcare Products Reports First Quarter Loss on Sales Decline 3Allied Healthcare Products Reports First Quarter Loss on Sales Decline 4FDA Statement on Makena 2
(Date:7/31/2015)... ... July 31, 2015 , ... Physical therapy for knee osteoarthritis is an ... life. It keeps the patient from doing what they want or need to do. The ... time using the stairs. The patient's exercise regime may be limited by the pain in ...
(Date:7/31/2015)... ... , ... The Radiology Business Management Association’s 2015 Fall Educational ... Health Care: A View From Capitol Hill” on Sunday, Sept. 27, 2015, in Austin, ... Burgess has a special understanding of the real world impact of health care policy ...
(Date:7/31/2015)... ... July 31, 2015 , ... In the most recent testosterone lawsuit ... the Northern District of Illinois, Androgel testosterone attorneys report that a “Mini Status Conference” ... was made recording the minutes of the status conference, which was held that day, ...
(Date:7/31/2015)... ... 2015 , ... Intellitec Solutions announced today they have expanded ... GP for a senior living facility in Maine. Having achieved recognition as a ... 16 states. This further expansion was again a factor of the firm’s success ...
(Date:7/30/2015)... ... ... When responsible for the care of an aging loved one, summer vacations ... What happens if mom falls? Who will remind Dad to take his medications? What ... not taking time away from caregiving responsibilities can lead to bigger problems – caregiver ...
Breaking Medicine News(10 mins):Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 2Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 4Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3
... , , , WHITE ... breakfasts and pie-throwing contests, Farmers Insurance agents nationwide led their communities to ... Dimes programs to give every baby a healthy start in life. , ... than $600,000 above this year,s goal. Farmers Insurance also matched public ...
... DETROIT, July 28 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... been appointed as interim Chief Executive Officer and as a ... Movens as Chief Executive Officer and as a Director effective ... Caraco experienced substantial product expansion and revenue growth. Mr. Movens ...
... MEK4 as a pro-invasion protein and the target for genistein, ... new study published online July 28 in the Journal ... Ph.D., and Raymond C. Bergan, M.D., of the Department of ... target for genistein in prostate cancer cells by assessing cell ...
... , Joliet Resident Hits Upon Many People,s ... 28 Carolyn Engers didn,t expect her call to go ... Today, the Joliet resident got answers directly from President Obama. ... nation for special Town Hall with the President and AARP leaders on ...
... , , , SAN ... become public following the planned spinoff of Cardinal Health,s clinical and medical ... spinoff has been declared effective by the Securities and Exchange Commission (SEC). ... Form 10 was one of the few remaining conditions to the planned ...
... , , , , ... and children from threat of "silver" dental fillings , ... the Food and Drug Administration (FDA) today did an about face ... stringent precautions for pregnant women and children. Last June, a court ...
Cached Medicine News:Health News:'Be a Hero For Babies Day' Raises $2.6 Million for March of Dimes 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO 2Health News:President Takes Illinois Woman's Tough Health Care Questions at AARP Town Hall 2Health News:CareFusion Form 10 Registration Statement Declared Effective 2Health News:CareFusion Form 10 Registration Statement Declared Effective 3Health News:CareFusion Form 10 Registration Statement Declared Effective 4Health News:FDA Ruling on Mercury Fillings Falls Short 2
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
Preassembled with Hot Top Assembly for oil-free cycling...
... Exceptional Performance The sleek lines ... be the first things you ... designed for performance. With benchspace ... its small footprint is the ...
... offers fast temperature control, exact block homogeneity, ... cards enable safe program storage as well ... protocols between different Mastercyclers. All models are ... with a two-year warranty. The Eppendorf ...
Medicine Products: